tranexamic acid has been researched along with Blood Poisoning in 4 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present study, we assessed the impact of inhibition of plasminogen activation by tranexamic acid on the course of staphylococcal sepsis and septic arthritis in mice." | 7.76 | Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis. ( Anäkkälä, N; Jin, T; Jonsson, IM; Kłak, M; Lange, S; Tarkowski, A; Wang, W, 2010) |
| "Tranexamic acid (TnxAc) is an antifibrinolytic agent that is being increasingly used to prevent and control bleeding in conditions such as elective orthopedic surgery, trauma, and post-partum-hemorrhage, which are frequently followed by infection and sepsis." | 5.51 | Hypofibrinolysis induced by tranexamic acid does not influence inflammation and mortality in a polymicrobial sepsis model. ( Annichinno-Bizzacchi, JM; Campos Nogueira, YA; de Lima, F; De Paula, EV; Gomes da Costa, LN; Levy, CE; Orsi, FA, 2019) |
| " In the present study, we assessed the impact of inhibition of plasminogen activation by tranexamic acid on the course of staphylococcal sepsis and septic arthritis in mice." | 3.76 | Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis. ( Anäkkälä, N; Jin, T; Jonsson, IM; Kłak, M; Lange, S; Tarkowski, A; Wang, W, 2010) |
| "Whereas in DIC associated with trauma, since balance between coagulation and fibrinolysis collapses drastically in a short period, both anticoagulantion therapy and antifibrinolytic therapy can be utilized depending on clinical conditions." | 2.53 | [Anti DIC therapy]. ( Sakamoto, Y; Yahata, M, 2016) |
| "Tranexamic acid (TnxAc) is an antifibrinolytic agent that is being increasingly used to prevent and control bleeding in conditions such as elective orthopedic surgery, trauma, and post-partum-hemorrhage, which are frequently followed by infection and sepsis." | 1.51 | Hypofibrinolysis induced by tranexamic acid does not influence inflammation and mortality in a polymicrobial sepsis model. ( Annichinno-Bizzacchi, JM; Campos Nogueira, YA; de Lima, F; De Paula, EV; Gomes da Costa, LN; Levy, CE; Orsi, FA, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campos Nogueira, YA | 1 |
| Gomes da Costa, LN | 1 |
| Levy, CE | 1 |
| Orsi, FA | 1 |
| de Lima, F | 1 |
| Annichinno-Bizzacchi, JM | 1 |
| De Paula, EV | 1 |
| Yahata, M | 1 |
| Sakamoto, Y | 1 |
| Kłak, M | 1 |
| Anäkkälä, N | 1 |
| Wang, W | 1 |
| Lange, S | 1 |
| Jonsson, IM | 1 |
| Tarkowski, A | 1 |
| Jin, T | 1 |
| Dolina, OA | 1 |
| Tiukov, VL | 1 |
| Gur'ianov, VA | 1 |
1 review available for tranexamic acid and Blood Poisoning
| Article | Year |
|---|---|
[Anti DIC therapy].
Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzamidines; Disseminated Intravascular Coa | 2016 |
3 other studies available for tranexamic acid and Blood Poisoning
| Article | Year |
|---|---|
Hypofibrinolysis induced by tranexamic acid does not influence inflammation and mortality in a polymicrobial sepsis model.
Topics: Animals; Antifibrinolytic Agents; Biomarkers; Cecum; Coinfection; Cytokines; Disease Models, Animal; | 2019 |
Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis.
Topics: Animals; Antifibrinolytic Agents; Arthritis, Infectious; Enterotoxins; Female; Fibrinolysin; Mice; M | 2010 |
[General anesthesia components during abdominal surgeries in patients with abdominal sepsis].
Topics: Abdomen; Adult; Aged; Anesthesia, General; Antifibrinolytic Agents; Aprotinin; Hemostatics; Humans; | 2005 |